Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.578 USD | -0.62% |
|
-10.12% | -28.99% |
Jul. 01 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
Jul. 01 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- Analyst Reco.